We found no major surprises in the annual report
Cash up 18% in 21 versus 20 (USD 216.2m vs USD 183.9m)
Research programs progressing
Webcast at 11.30 a.m. CET, presentation available on web page
01 Apr 2022
Arctic FLASH: Nykode Therapeutics AS - Annual report: Frist look
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Arctic FLASH: Nykode Therapeutics AS - Annual report: Frist look
Nykode Therapeutics ASA (NYKD:OSL) | 0 0 0.0%
- Published:
01 Apr 2022 -
Author:
Lars Mørland Knudsen -
Pages:
6 -
We found no major surprises in the annual report
Cash up 18% in 21 versus 20 (USD 216.2m vs USD 183.9m)
Research programs progressing
Webcast at 11.30 a.m. CET, presentation available on web page